34 related articles for article (PubMed ID: 10089074)
1. Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk.
Hwang SJ; Lozano G; Amos CI; Strong LC
Am J Hum Genet; 2003 Apr; 72(4):975-83. PubMed ID: 12610779
[TBL] [Abstract][Full Text] [Related]
2. Pathogenic Loss-of-Function Germline
Walsh MF; Sacca R; Wildman T; Amoroso K; Kennedy J; Zhang L; Birsoy O; Mandelker D; Steinsnyder Z; Latham A; Carlo MI; Cadoo K; Kemel Y; Robson M; Stadler ZK; Offit K
JCO Precis Oncol; 2019; 3():. PubMed ID: 32923861
[No Abstract] [Full Text] [Related]
3. Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
Chang MT; Asthana S; Gao SP; Lee BH; Chapman JS; Kandoth C; Gao J; Socci ND; Solit DB; Olshen AB; Schultz N; Taylor BS
Nat Biotechnol; 2016 Feb; 34(2):155-63. PubMed ID: 26619011
[TBL] [Abstract][Full Text] [Related]
4. Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.
Yurgelun MB; Allen B; Kaldate RR; Bowles KR; Judkins T; Kaushik P; Roa BB; Wenstrup RJ; Hartman AR; Syngal S
Gastroenterology; 2015 Sep; 149(3):604-13.e20. PubMed ID: 25980754
[TBL] [Abstract][Full Text] [Related]
5. A young woman with bilateral breast cancer: identifying a genetic cause and implications for management.
de Bruin MA; Ford JM; Kurian AW
J Natl Compr Canc Netw; 2013 May; 11(5):512-7. PubMed ID: 23667202
[TBL] [Abstract][Full Text] [Related]
6. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.
Ruijs MW; Verhoef S; Rookus MA; Pruntel R; van der Hout AH; Hogervorst FB; Kluijt I; Sijmons RH; Aalfs CM; Wagner A; Ausems MG; Hoogerbrugge N; van Asperen CJ; Gomez Garcia EB; Meijers-Heijboer H; Ten Kate LP; Menko FH; van 't Veer LJ
J Med Genet; 2010 Jun; 47(6):421-8. PubMed ID: 20522432
[TBL] [Abstract][Full Text] [Related]
7. Astrocytomas and choroid plexus tumors in two families with identical p53 germline mutations.
Vital A; Bringuier PP; Huang H; San Galli F; Rivel J; Ansoborlo S; Cazauran JM; Taillandier L; Kleihues P; Ohgaki H
J Neuropathol Exp Neurol; 1998 Nov; 57(11):1061-9. PubMed ID: 9825943
[TBL] [Abstract][Full Text] [Related]
8. Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families.
Varley JM; McGown G; Thorncroft M; Santibanez-Koref MF; Kelsey AM; Tricker KJ; Evans DG; Birch JM
Cancer Res; 1997 Aug; 57(15):3245-52. PubMed ID: 9242456
[TBL] [Abstract][Full Text] [Related]
9. Screening for germ line p53 mutations in children with malignant tumors and a family history of cancer.
Brugières L; Gardes M; Moutou C; Chompret A; Meresse V; Martin A; Poisson N; Flamant F; Bonaïti-Pellié C; Lemerle J
Cancer Res; 1993 Feb; 53(3):452-5. PubMed ID: 8425176
[TBL] [Abstract][Full Text] [Related]
10. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.
Malkin D; Li FP; Strong LC; Fraumeni JF; Nelson CE; Kim DH; Kassel J; Gryka MA; Bischoff FZ; Tainsky MA
Science; 1990 Nov; 250(4985):1233-8. PubMed ID: 1978757
[TBL] [Abstract][Full Text] [Related]
11. Germline TP53 mutations and single nucleotide polymorphisms in children.
Valva P; Becker P; Streitemberger P; Lombardi GM; Rey G; Guzman CA; Preciado MV
Medicina (B Aires); 2009; 69(1 Pt 2):143-7. PubMed ID: 19414295
[TBL] [Abstract][Full Text] [Related]
12. Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias.
Marx SJ; Agarwal SK; Kester MB; Heppner C; Kim YS; Skarulis MC; James LA; Goldsmith PK; Saggar SK; Park SY; Spiegel AM; Burns AL; Debelenko LV; Zhuang Z; Lubensky IA; Liotta LA; Emmert-Buck MR; Guru SC; Manickam P; Crabtree J; Erdos MR; Collins FS; Chandrasekharappa SC
Recent Prog Horm Res; 1999; 54():397-438; discussion 438-9. PubMed ID: 10548885
[TBL] [Abstract][Full Text] [Related]
13. Tumors associated with p53 germline mutations: a synopsis of 91 families.
Kleihues P; Schäuble B; zur Hausen A; Estève J; Ohgaki H
Am J Pathol; 1997 Jan; 150(1):1-13. PubMed ID: 9006316
[TBL] [Abstract][Full Text] [Related]
14. Germline mutations of the p53 gene in children with malignant solid tumors.
Ayan I; Luca JW; Jaffe N; Yazici H; Ekmekçioğlu S; Hansen MF
J Exp Clin Cancer Res; 1998 Dec; 17(4):497-502. PubMed ID: 10089074
[TBL] [Abstract][Full Text] [Related]
15. Screening for germline p53 mutations in pediatric and adult patients of high-risk groups in Poland.
Fiszer-Maliszewska L; Czernik J; Sawicz-Birkowska K; Perek D; Kozera M; Wojciechowska B; Kazanowska B; Hudziec P; Kilar E
Arch Immunol Ther Exp (Warsz); 2000; 48(4):309-15. PubMed ID: 11059649
[TBL] [Abstract][Full Text] [Related]
16. Microsatellite instability and p53 mutations in pediatric secondary malignant neoplasms.
Gafanovich A; Ramu N; Krichevsky S; Pe'er J; Amir G; Ben-Yehuda D
Cancer; 1999 Jan; 85(2):504-10. PubMed ID: 10023722
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
